Characterization of mono- and diaminopyrimidine derivatives as novel, nonpeptide gonadotropin releasing hormone (GnRH) receptor antagonists
摘要:
A novel series of derivatives of mono- and diaminopyrimidines 1 potently displaced binding of a radiolabeled GnRH analogue to human and rat GnRH receptors. Analogues from these series competitively antagonized GnRH-stimulated increases in extracellular acidification in vitro and suppressed GnRH-mediated increases in circulating luteinizing hormone (LH) in castrated rats and testosterone in intact rats. These compounds or their analogues may be useful in treating sex hormone-dependent disease. (C) 2002 Elsevier Science Ltd. All rights reserved.
NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
申请人:Agouron Pharmaceuticals, Inc.
公开号:EP1401427A2
公开(公告)日:2004-03-31
EP1401427A4
申请人:——
公开号:EP1401427A4
公开(公告)日:2004-12-01
US7101878B1
申请人:——
公开号:US7101878B1
公开(公告)日:2006-09-05
[EN] NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION<br/>[FR] AGENTS NON PEPTIDIQUES DE L'HORMONE DE LIBERATION DE LA GONADOTROPHINE ET INTERMEDIAIRES UTILES POUR LES PREPARER
申请人:AGOURON PHARMA
公开号:WO2000020358A2
公开(公告)日:2000-04-13
Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, multimers, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.